Michele Paz

Michele (Leddy) Paz has extensive work experience in finance and strategic planning. In 2010, they started their career at Pfizer, where they worked in finance portfolio management optimization and global finance restructuring until 2014. In 2015, they had a summer associate role in healthcare investment banking at Credit Suisse. Paz then rejoined Pfizer in 2016, focusing on corporate development. From 2017 to 2023, they held various roles at Regeneron Pharmaceuticals, including senior manager in genetics business operations and strategic planning, as well as manager in the genetics center. Currently, Paz is the director of finance at Cara Therapeutics since April 2023.

Michele (Leddy) Paz received a Master of Business Administration (MBA) degree with a dual concentration in Financial Analysis & Strategy from Duke University - The Fuqua School of Business. Prior to that, they earned a Bachelor of Science in Business Administration (BSBA) from Bucknell University, with a double major in Business Management and Political Science, and a minor in Italian Studies. Michele attended St. Anthony's High School, but no specific degrees or fields of study are mentioned.